CD133+ hepatocellular carcinoma cell population exhibited therapeutic resistance to chemotherapeutic agents by activating Akt signaling pathway as well as Wnt/β‐catenin pathway [113, 114]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.